查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1912751

家用採血針市場按產品類型、規格、材質和銷售管道－全球預測（2026-2032 年）

Home Use Lancets Market by Product Type, Gauge, Material, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，家用採血針市場價值將達到 14.2 億美元，到 2026 年將成長至 14.9 億美元，到 2032 年將達到 22.8 億美元，複合年成長率為 6.94%。

主要市場統計數據
基準年 2025 14.2億美元
預計年份：2026年 14.9億美元
預測年份：2032年 22.8億美元
複合年成長率 (%) 6.94%

全面概述家用採血針的發展趨勢，包括產品設計、使用者需求、法規環境和分銷趨勢，這些因素共同影響著設備的普及應用。

家用採血針結合了符合人體工學的設計、安全特性和使用者信心，仍然是支持日常糖尿病自我管理實踐的關鍵組成部分。本報告將採血針產品置於更廣泛的患者需求、臨床指南和分銷管道變化等影響產品選擇和應用的因素中進行整體情況變化的設備偏好、監管預期和用戶群特徵如何共同塑造產品開發重點和商業策略。

產品設計、監管、供應鏈韌性和數位健康整合等領域的新興趨勢正在重新定義《採血針》生態系統的優先事項和商業策略。

採血針市場正經歷著變革性的轉變，使用者體驗優先、監管日益嚴格以及數位化醫療的整合是推動變革的主要因素，這正在重塑製造商和經銷商的產品設計和通路策略。使用者對疼痛感最小化、插入深度一致性和操作直覺性的期望，使得自動化解決方案和先進的使用者介面變得愈發重要，促使產品藍圖更加重視效能和使用者體驗的舒適度。

2025年美國關稅調整對家用採血設備製造商和經銷商的採購、採購策略和競爭利潤率的影響

2025年美國關稅環境對家用醫療設備的製造商、進口商和下游經銷商構成重大挑戰，並對業務營運和定價產生連鎖反應。重新設計的關稅正在影響零件和成品的成本結構，進而影響採購選擇和庫存策略，因為企業正在尋求降低到岸成本。因此，採購部門正在重新評估其供應商組合，並考慮近岸外包和多元化經營，以穩定供應鏈並維持可預測的交貨期。

將產品設計、最終用戶需求、分銷管道、規格選擇和材料選擇與產品策略和用戶採納聯繫起來的多維度細分分析

產品細分洞察突顯了創新與商業性重點的整合領域，以及持續存在的未滿足需求。產品類型涵蓋從手動設備到自動採血系統，其中自動解決方案明顯區分了非回縮式設計和回縮式型號，後者優先考慮使用後針頭的隱藏。同時，手動設備又分為非彈簧式和彈簧式設計，後者旨在實現穩定且便利的操作。這種層級式產品分類系統影響設計者的優先事項，因為他們需要在觸覺回饋、深度控制和安全處置之間尋求平衡，並驅動著製造商的研發策略。

區域策略概述，比較美洲、歐洲、中東和非洲以及亞太地區的監管複雜性、流通結構和消費者偏好。為目標市場進入和成長提供指南。

區域趨勢影響監管要求、分銷複雜性和消費者偏好，從而為每個主要地理區域叢集創造了獨特的策略要務。在美洲，成熟的糖尿病照護管道和廣泛的零售藥房網路確保了產品的快速供應和與消費者的直接互動。同時，某些地區的健保報銷環境和採購競標也會影響定價策略和通路優先順序。在該地區運營的製造商往往注重便捷的包裝、患者教育材料和臨床合作項目，以提高患者的用藥依從性。

主要製造商之間的競爭格局和策略性舉措強調產品差異化、夥伴關係和分銷策略，以創造永續的商業性優勢。

領先製造商之間的競爭格局呈現出多元化的態勢，這些態勢體現在產品創新、策略聯盟和分銷管道等方面。主要參與企業正致力於研發差異化的安全功能、精密的深度控制機制以及包裝創新，以提高病患的理解能力和確保處置安全性。與數位醫療公司和血糖監測系統供應商的合作日益普遍，從而實現整合的使用者體驗和交叉促銷，使設備的用途超越一次性使用。

將產品創新、全通路分銷和供應鏈韌性相結合，以實現永續競爭優勢，這其中存在著切實的策略挑戰。

產業領導者應優先考慮整合產品創新、通路執行和監管準備的策略，以獲取長期價值。人體工學和低痛感機制的投資能夠增強產品在高頻用戶群中的定位，而模組化設計方法則能夠實現快速迭代和對不同管理體制的本地化調整。賦能跨職能團隊，將設計、監管和供應鏈決策連結起來，可以減少因合規性主導的產品變更而產生的摩擦，並加快對關稅和採購衝擊的反應速度。

我們採用透明的多資訊來源調查方法，結合關鍵相關人員訪談、監管審查和三角驗證分析，以確保研究結果切實可行且經得起推敲。

本研究採用多層次調查方法，整合了主要研究結果和次要訊息，強調資料的完整性、可重複性和專家檢驗。主要資料來源包括對醫療設備設計師、採購經理、藥劑師和熟悉自我給藥實務的臨床醫生進行的結構化訪談。這些訪談提供了深入的定性分析，將觀察到的商業性模式置於具體的背景中，重點關注易用性、分銷管道特徵和營運限制。訪談樣本的選擇優先考慮了地域多樣性和不同規模的組織，以反映不同的營運實際情況。

綜合分析表明，卓越的設計、靈活的監管適應能力和成熟的分銷管道是家用採血設備實現永續成功的基礎。

本報告總結了參與家用採血針設計、分銷和採購的相關人員最重要的見解，重點闡述了用戶體驗、監管壓力和不斷變化的配銷通路如何共同塑造產品方向。自動化採血系統的進步和手動採血針設計的改進，提高了人們對無痛採血、安全性和性能穩定性的期望。同時，為了滿足不同終端使用者的需求，例如孕婦、1 型糖尿病患者和第 2 型糖尿病患者，需要針對每個使用者群體量身定做價值提案。產品屬性（例如規格和材料）與分銷管道趨勢之間的相互作用，會影響用戶滿意度和重購率。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依產品類型分類的家用採血針市場

  • 自動的
    • 非彈簧式
    • 彈簧型
  • 手動輸入
    • 非彈簧式
    • 彈簧型

第9章 家用採血針市場（依規格分類）

  • 28號口徑
  • 30號口徑
  • 31號口徑
  • 32號口徑

第10章 家用採血針市場（依材料分類）

  • 塑膠
  • 防鏽的

第11章 家用採血針市場銷售管道

  • 線上
  • 藥局

第12章：各地區家用採血針市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 家用採血針市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國家用採血針市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國家庭採血針市場

第17章：中國家用採血針市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Arkray, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • F. Hoffmann-La Roche AG
  • LifeScan, LLC
  • Menarini Diagnostics Srl
  • Nipro Corporation
  • Owen Mumford Ltd.
  • Terumo Corporation
Product Code: MRR-AE420CB13A75

The Home Use Lancets Market was valued at USD 1.42 billion in 2025 and is projected to grow to USD 1.49 billion in 2026, with a CAGR of 6.94%, reaching USD 2.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.42 billion
Estimated Year [2026] USD 1.49 billion
Forecast Year [2032] USD 2.28 billion
CAGR (%) 6.94%

A comprehensive orientation to home-use lancet dynamics that establishes product design, user needs, regulatory context, and distribution trends shaping device adoption

Home-use lancets remain a critical component of self-monitoring practices, blending ergonomic design, safety features, and user confidence to support daily diabetes management. This report introduces the landscape by situating lancet products within broader patient needs, clinical guidance, and distribution shifts that influence product choice and adoption. It explores how evolving device preferences, regulatory expectations, and user demographics converge to shape product development priorities and commercial strategies.

The introduction frames the technology continuum from simple manual devices to increasingly automated solutions that prioritize comfort, consistency, and reduced needlestick risk. It also notes the influence of adjacent innovations such as blood glucose monitoring platforms and telehealth protocols that reinforce the centrality of reliable capillary sampling. Throughout, the discussion highlights how human factors engineering and supply chain resilience are as consequential as material and gauge selection when evaluating product viability.

This section establishes the report's analytical approach, emphasizing comparative evaluation across product design categories and end-user segments. It underscores the importance of integrating clinical usability studies, regulatory guidance, and distribution behavior in forming practical recommendations. By grounding the analysis in real-world user requirements and operational constraints, the introduction positions readers to interpret subsequent sections with a focus on actionable outcomes and strategic alignment.

Emerging forces in product design, regulation, supply resilience, and digital health integration that are redefining priorities and commercial strategies across the lancet ecosystem

The lancet landscape is experiencing transformative shifts driven by user experience priorities, regulatory tightening, and digital health integration, reshaping how manufacturers and distributors approach product design and channel strategies. User expectations for pain minimization, consistency of puncture depth, and intuitive operation are elevating the importance of automated solutions and refined user interfaces, prompting product roadmaps that emphasize both performance and emotional comfort.

Regulatory frameworks are tightening in major markets, raising requirements for labeling, safety mechanisms, and post-market surveillance. These developments in policy reinforce manufacturers' need to embed traceability and adverse event reporting capabilities in product lifecycles. Concurrently, the rise of integrated personal health ecosystems-where lancets feed into connected glucose monitoring and telemedicine workflows-creates a demand for compatibility, standardized user instructions, and packaging that supports multi-device households.

Supply chain resilience and sustainability considerations are also catalyzing innovation. Material choices and design for recyclability are becoming important differentiators, as procurement teams and informed consumers look to reduce single-use environmental footprints. Finally, distribution is fragmenting: direct-to-consumer channels are complemented by pharmacy networks and digital retailers, requiring omnichannel strategies that balance clinical guidance, consumer education, and efficient fulfillment. Together, these shifts are redefining priorities for product development, regulatory planning, and commercial execution.

How the 2025 US tariff adjustments are reshaping procurement, sourcing strategies, and competitive margins for manufacturers and distributors of home-use blood sampling devices

The United States tariff landscape in 2025 has introduced material considerations for manufacturers, importers, and downstream distributors of home-use medical devices, with cascading operational and pricing implications. Tariff redesigns affect cost structures for components and finished products, influencing sourcing choices and inventory strategies as companies seek to mitigate elevated landed costs. As a result, procurement teams are reevaluating supplier portfolios and considering nearshoring or diversification to stabilize supply lines and maintain predictable fulfillment windows.

Tariff-related cost pressures also alter competitive positioning among players who rely on international manufacturing. Organizations with vertically integrated operations or diversified production footprints are better insulated against import duty volatility, while smaller suppliers may experience squeezes on margin that constrain investment in design improvements or regulatory readiness. In some cases, distributors adjust pricing frameworks or absorb portions of duty increases temporarily to preserve customer relationships, creating short-term margin trade-offs.

Regulatory compliance costs interact with tariff effects to shape go-to-market timing and packaging decisions. Companies reassess whether to consolidate SKUs, redesign packaging for cost-effective cross-border compliance, or localize certain production steps to reduce tariff exposure. These combined forces underscore the need for dynamic scenario planning, proactive customs classification reviews, and heightened collaboration between regulatory, procurement, and commercial teams to preserve continuity and protect end-user access to critical self-monitoring tools.

A multidimensional segmentation analysis that links product designs, end-user needs, sales channels, gauge selection, and material choices to product strategy and user adoption

Insight into product segmentation clarifies where innovation and commercial focus are converging and where unmet needs persist. The product type spectrum ranges from manual devices to automated lancing systems; within automatic solutions there is a clear distinction between non-retraction designs and retraction-enabled models that prioritize needle concealment post-use, while manual alternatives are split between non spring loaded options and spring loaded designs that enhance consistency and ease of activation. This layered product taxonomy influences manufacturer R&D priorities, as designers balance tactile feedback, depth control, and safe disposal features.

End-user segmentation further refines demand dynamics. Users managing gestational glucose monitoring bring distinct frequency and comfort concerns compared with individuals with type 1 diabetes who often require higher-frequency sampling and therefore place premium value on consistency and low-pain profiles, while people with type 2 diabetes may prioritize affordability and ease of use for less intensive monitoring routines. Channel segmentation reveals evolving purchase behaviors: online pathways include direct-to-consumer procurement and purchases through third-party retailers, whereas pharmacy channels encompass both chain and independent outlets that differ in stocking strategies, pharmacist counseling roles, and point-of-sale education.

Technical attributes including gauge options-spanning 28 gauge to 32 gauge-drive perceptions of pain and sample adequacy, with smaller gauge numbers typically associated with larger needle diameters. Material choices between plastic and stainless steel affect tactile feel, recyclability, and cost profiles, shaping procurement decisions for health systems and consumer preferences for perceived durability. Together, these segmentation lenses provide a multidimensional framework for assessing product fit, competitive differentiation, and targeted messaging.

A regional strategic brief that contrasts regulatory complexity, distribution structures, and consumer preferences across the Americas, Europe Middle East & Africa, and Asia-Pacific for targeted market entry and growth

Regional dynamics shape regulatory expectations, distribution complexity, and consumer preferences, creating distinct strategic imperatives across major geographic clusters. In the Americas, established diabetes care pathways and broad retail pharmacy networks support rapid product availability and significant direct-to-consumer engagement, while reimbursement environments and procurement tenders in some jurisdictions influence pricing strategies and channel prioritization. Manufacturers operating in this region often emphasize convenient packaging, patient education materials, and partnership programs with clinical organizations to drive adherence.

In Europe, the Middle East & Africa region, regulatory harmonization efforts and national-level medical device directives create a mosaic of compliance requirements that favor manufacturers with robust regulatory affairs capabilities and localized market entry plans. Distribution channels vary widely, from consolidated chain pharmacies in some markets to decentralized independent outlets in others, necessitating adaptable logistics and tailored pharmacist training initiatives. Cultural preferences and climate considerations also influence material selection and packaging formats.

Across the Asia-Pacific region, rapid adoption of digital health tools and strong manufacturing ecosystems create both opportunity and competition. High-volume distribution channels, growing online retail penetration, and diverse patient profiles require nimble supply strategies and scalable production capacity. In several markets, price sensitivity is balanced by strong demand for convenience and minimized pain, encouraging manufacturers to offer tiered product portfolios that address both premium and value segments. These regional distinctions inform prioritization of investment, regulatory planning, and channel partnerships.

Competitive patterns and strategic maneuvers among leading manufacturers emphasizing product differentiation, partnerships, and distribution plays that drive enduring commercial advantage

Competitive dynamics among leading manufacturers reveal a mix of product innovation, strategic partnerships, and distribution-focused plays that shape the competitive landscape. Key players are investing in differentiated safety features, refined depth-control mechanisms, and packaging innovations that improve patient comprehension and disposal safety. Collaborations with digital health firms and glucose monitoring system providers are increasingly common, enabling integrated user experiences and cross-promotional opportunities that extend device relevance beyond single-use interactions.

Mergers, acquisitions, and licensing agreements remain important mechanisms for accessing advanced technologies and regional distribution networks. Acquirers often target companies with proprietary user-centric designs or regulatory approvals in strategic territories, accelerating time-to-market for enhanced lancet portfolios. At the same time, alliances with pharmacy chains and e-commerce platforms secure shelf presence and optimize fulfillment logistics, reinforcing channels that drive recurring purchases.

Smaller specialized manufacturers are leveraging nimble engineering cycles to pilot novel materials and recyclable packaging, carving niche positions around sustainability claims or premium comfort. Pricing strategies vary by distribution channel and customer segment, with value offerings aimed at high-volume users and premium lines focused on low-pain automated experiences. These competitive patterns suggest that sustained investment in product differentiation, regulatory capability, and omnichannel presence will determine which companies convert product innovation into durable commercial advantage.

Actionable strategic imperatives for manufacturers and distributors to align product innovation, omnichannel distribution, and supply resilience for durable competitive performance

Industry leaders should prioritize integrated strategies that align product innovation with channel execution and regulatory readiness to capture long-term value. Investing in ergonomics and low-pain mechanisms can strengthen product positioning among high-frequency users while modular design approaches enable faster iteration and localized adaptation for diverse regulatory regimes. Strengthening cross-functional teams that link design, regulatory affairs, and supply chain decision-making reduces the friction of compliance-driven product changes and accelerates responsiveness to tariff or sourcing shocks.

Expanding omnichannel capabilities is essential. Direct-to-consumer platforms should be complemented by robust pharmacy partnerships and third-party retail distribution to balance reach and clinical counsel. Initiatives that support pharmacist education and patient onboarding tools will enhance adherence and product perception at the point of care. Simultaneously, pilot programs that integrate lancets into connected glucose monitoring ecosystems create opportunities for bundled solutions that increase customer lifetime value and improve clinical data capture.

Operationally, manufacturers should pursue supplier diversification and scenario-based procurement models to mitigate import duty and logistical risks. Sustainable material strategies, including recyclable packaging and reduced single-use plastics, can strengthen brand differentiation and anticipate tightening environmental regulations. Finally, consider targeted M&A or licensing to acquire specialty designs or regional market access, ensuring that expansion accelerates capability rather than dilutes focus. Executed together, these measures will help organizations convert product strengths into resilient commercial performance.

A transparent, multi-source research methodology combining primary stakeholder interviews, regulatory review, and triangulated analysis to ensure actionable and defensible findings

This research synthesizes primary insights and secondary sources through a layered methodology that emphasizes data integrity, reproducibility, and expert validation. Primary inputs include structured interviews with device designers, procurement leads, pharmacists, and clinicians experienced in self-monitoring practices. These conversations focused on usability, channel behaviors, and operational constraints, providing qualitative depth that contextualizes observed commercial patterns. Interview sampling prioritized geographic diversity and a range of organizational sizes to capture differing operational realities.

Secondary research incorporated regulatory documents, product literature, and peer-reviewed clinical ergonomics studies to map compliance trajectories and user-centric design benchmarks. Trade publications and logistics performance indicators were consulted to understand distribution trends and supply chain stressors. Data triangulation techniques were applied to reconcile differences between stakeholder accounts and documented operational metrics, ensuring conclusions reflect convergent evidence rather than single-source assertions.

Analytical steps included segmentation mapping, scenario analysis for tariff and sourcing variations, and comparative feature benchmarking across product types, gauges, and material choices. Quality assurance encompassed cross-validation of interview summaries with source participants, independent review by technical subject-matter experts, and consistency checks to ensure that regulatory references were current as of the final analysis. The methodology prioritizes transparent sourcing and defensible inference to support practical decision-making.

Consolidated findings that emphasize design excellence, regulatory agility, and channel sophistication as the pillars of sustainable success in home-use blood sampling devices

This report consolidates the most consequential insights for stakeholders engaged in the design, distribution, and procurement of home-use lancets, underscoring how user experience, regulatory pressures, and channel evolution jointly shape product trajectories. Advances in automated lancing systems and refinements to manual designs are raising expectations for low-pain sampling, safety, and consistent performance, while diverse end-user needs require tailored value propositions across gestational, type 1, and type 2 user profiles. The interaction between product attributes such as gauge and material and channel dynamics influences user satisfaction and repeat purchasing.

Regional and tariff-related forces highlight the strategic importance of adaptable supply chains, regulatory foresight, and targeted distribution partnerships. Manufacturers that couple ergonomic innovation with regulatory competence and omnichannel execution are positioned to capitalize on shifting preferences. Sustainability and lifecycle considerations are becoming differentiators, prompting product teams to weigh material selection and end-of-life handling in future roadmaps.

In sum, success in the home-use lancet domain will favor organizations that integrate human-centered design, compliance agility, and channel sophistication into cohesive strategies. Stakeholders should act on the report's insights to refine product portfolios, optimize distribution models, and strengthen resilience against external shocks, thereby enhancing user outcomes and long-term operational stability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home Use Lancets Market, by Product Type

  • 8.1. Automatic
    • 8.1.1. Non Retraction
    • 8.1.2. Retraction
  • 8.2. Manual
    • 8.2.1. Non Spring Loaded
    • 8.2.2. Spring Loaded

9. Home Use Lancets Market, by Gauge

  • 9.1. 28 Gauge
  • 9.2. 30 Gauge
  • 9.3. 31 Gauge
  • 9.4. 32 Gauge

10. Home Use Lancets Market, by Material

  • 10.1. Plastic
  • 10.2. Stainless Steel

11. Home Use Lancets Market, by Sales Channel

  • 11.1. Online
  • 11.2. Pharmacy

12. Home Use Lancets Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Home Use Lancets Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Home Use Lancets Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Home Use Lancets Market

16. China Home Use Lancets Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Arkray, Inc.
  • 17.7. Ascensia Diabetes Care Holdings AG
  • 17.8. B. Braun Melsungen AG
  • 17.9. F. Hoffmann-La Roche AG
  • 17.10. LifeScan, LLC
  • 17.11. Menarini Diagnostics S.r.l.
  • 17.12. Nipro Corporation
  • 17.13. Owen Mumford Ltd.
  • 17.14. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOME USE LANCETS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOME USE LANCETS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOME USE LANCETS MARKET SIZE, BY GAUGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME USE LANCETS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOME USE LANCETS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON RETRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON RETRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON RETRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOME USE LANCETS MARKET SIZE, BY RETRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOME USE LANCETS MARKET SIZE, BY RETRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOME USE LANCETS MARKET SIZE, BY RETRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOME USE LANCETS MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOME USE LANCETS MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOME USE LANCETS MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON SPRING LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON SPRING LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON SPRING LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOME USE LANCETS MARKET SIZE, BY SPRING LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOME USE LANCETS MARKET SIZE, BY SPRING LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOME USE LANCETS MARKET SIZE, BY SPRING LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOME USE LANCETS MARKET SIZE, BY 28 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOME USE LANCETS MARKET SIZE, BY 28 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOME USE LANCETS MARKET SIZE, BY 28 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOME USE LANCETS MARKET SIZE, BY 30 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOME USE LANCETS MARKET SIZE, BY 30 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOME USE LANCETS MARKET SIZE, BY 30 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOME USE LANCETS MARKET SIZE, BY 31 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOME USE LANCETS MARKET SIZE, BY 31 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOME USE LANCETS MARKET SIZE, BY 31 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOME USE LANCETS MARKET SIZE, BY 32 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOME USE LANCETS MARKET SIZE, BY 32 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOME USE LANCETS MARKET SIZE, BY 32 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOME USE LANCETS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOME USE LANCETS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOME USE LANCETS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOME USE LANCETS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOME USE LANCETS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOME USE LANCETS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOME USE LANCETS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOME USE LANCETS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOME USE LANCETS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOME USE LANCETS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOME USE LANCETS MARKET SIZE, BY PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOME USE LANCETS MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOME USE LANCETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS HOME USE LANCETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOME USE LANCETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. GCC HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GCC HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. GCC HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 118. GCC HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 119. GCC HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 120. GCC HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. GCC HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. G7 HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. G7 HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. G7 HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 139. G7 HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 140. G7 HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 141. G7 HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. G7 HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. NATO HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. NATO HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. NATO HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 146. NATO HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 147. NATO HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 148. NATO HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. NATO HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)